[Pharmacokinetic interaction between valproic acid and meropenem]
F Sala Piñol, N Padullés Zamora, E Hidalgo Albert, S Clemente Bautista, M J Cabañas Poy, M Oliveras Arenas, J Balcells Ramírez
Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría (A.E.P.) 2006, 64 (1): 93-5
16539924
Several reports have described a decrease in valproic acid (VPA) serum concentrations when carbapenem therapy is administered. The exact mechanism of this pharmacokinetic interaction is unknown, although several experimental studies have been carried out in animals. Because of these interactions, plasma concentrations of VPA in these patients should be monitored and, whenever possible, VPA or carbapenem therapy should be substituted by other drugs. We describe the cases of two epileptic children who simultaneously received meropenem and VPA. Concentrations of VPA decreased to subtherapeutic levels. We review the various mechanisms for this interaction proposed to date, as well as all reported cases.
Read this article (multiple options)
Related Papers
You are not logged in. Sign Up or Log In to join the discussion.